![Franck Lescure](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Franck Lescure
Directeur/Membre du Conseil chez
iDbyMe SA
Profil
Franck Lescure is currently a Director at iDbyMe SA, Isocell SA, Fabentech SAS, and EnobraQ SAS. He is also a Partner at Elaia Partners SAS and a Member-Supervisory Board at Flash Therapeutics SAS and Pylote SA. In the past, he was a Director at Domain Therapeutics SA, MEDIAN Technologies SA, ERYTech Pharma SA, Stantum SAS, Tc Land Expression SA, Sangamo Therapeutics France SAS, CYTOO SA, Convertigo SA, BonitaSoft SA, eXo Platform SAS, and Miliboo SA. He was also a Product Manager at Air Liquide SA. From 2010 to 2018, he was a Partner at Auriga Partners SA. He has also served as a Member-Supervisory Board at Availpro SAS, Amoéba SA, Pherecydes Pharma SA, and Nosopharm SAS. Dr. Lescure holds a doctorate from École Normale Supérieure and an MBA from College des Ingenieurs.
Postes actifs de Franck Lescure
| Sociétés | Poste | Début |
|---|---|---|
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Private Equity Investor | 01/04/2004 |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Directeur/Membre du Conseil | 12/06/2014 |
iDbyMe SA
 iDbyMe SA Catalog/Specialty DistributionRetail Trade Sells clothes online | Directeur/Membre du Conseil | - |
Isocell SA
 Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Directeur/Membre du Conseil | - |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Directeur/Membre du Conseil | - |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Directeur/Membre du Conseil | - |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia is an active, long-term manager which invests in software technology companies, primarily in France and on a case by case basis in other European countries. The firm typically invests €1-€2 million, alone or through syndicated rounds, allocating additional financing to the future financing needs of the investee company. Elaia's investment strategy aims to maximize diversification within software-related technologies. They seek to create a balanced portfolio allocation based on four diversification criteria: development stage, geographical location, economic model and market segment. The firm invests in companies in all development stages, with an emphasis on first rounds of venture capital and the ability to participate in special situations. This multi-stage approach generates a broad range of risk/reward profiles and different exit perspectives. They diversify by sector and economic model to address the widest range of opportunities within the software-related field. By diversifying geographically, they aim to allocate approximately 20% of their portfolio to European opportunities outside France, to provide better access to an international network and enlarge their understanding of the markets. Elaia participates as lead investor or as a follower in a syndicate, typically seeking a board position to accompany the management team through the key stages of the investee company's development, aiming to add value to the company. The firm seeks to invest in innovative, well-managed, high-growth companies in large, appealing markets, which meet customer's needs, ideally have an existing customer base, a realistic and sustainable business model and reasonable company valuation. | Private Equity Investor | 01/06/2018 |
Pylote SA
 Pylote SA BiotechnologyHealth Technology Conceives and develops mineral microspheres to sell solutions | Directeur/Membre du Conseil | 01/01/2015 |
Flash Therapeutics SAS
 Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Provides biotechnology products for medical research | Directeur/Membre du Conseil | 01/01/2016 |
Anciens postes connus de Franck Lescure
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Franck Lescure
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Air Liquide SA
 Air Liquide SA Chemicals: SpecialtyProcess Industries Supplies gases, technologies and services for the industry & health businesses | Process Industries |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners invests in small and mid sized companies located in France and Europe. The firm targets companies operating in the fields of IT and life science sectors. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 1 - 5 million and also take minority stakes. | Finance |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Elaia Partners SAS
Elaia Partners SAS Investment ManagersFinance Elaia is an active, long-term manager which invests in software technology companies, primarily in France and on a case by case basis in other European countries. The firm typically invests €1-€2 million, alone or through syndicated rounds, allocating additional financing to the future financing needs of the investee company. Elaia's investment strategy aims to maximize diversification within software-related technologies. They seek to create a balanced portfolio allocation based on four diversification criteria: development stage, geographical location, economic model and market segment. The firm invests in companies in all development stages, with an emphasis on first rounds of venture capital and the ability to participate in special situations. This multi-stage approach generates a broad range of risk/reward profiles and different exit perspectives. They diversify by sector and economic model to address the widest range of opportunities within the software-related field. By diversifying geographically, they aim to allocate approximately 20% of their portfolio to European opportunities outside France, to provide better access to an international network and enlarge their understanding of the markets. Elaia participates as lead investor or as a follower in a syndicate, typically seeking a board position to accompany the management team through the key stages of the investee company's development, aiming to add value to the company. The firm seeks to invest in innovative, well-managed, high-growth companies in large, appealing markets, which meet customer's needs, ideally have an existing customer base, a realistic and sustainable business model and reasonable company valuation. | Finance |
MEDIAN Technologies SA
 MEDIAN Technologies SA Medical/Nursing ServicesHealth Services Engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology | Health Services |
École Normale Supérieure
 École Normale Supérieure Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Availpro SAS
 Availpro SAS Other Consumer ServicesConsumer Services Provides hotel online reservation solutions | Consumer Services |
Stantum SAS
 Stantum SAS SemiconductorsElectronic Technology Provides multi-touch display technologies and components | Electronic Technology |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Commercial Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
Convertigo SA
 Convertigo SA Packaged SoftwareTechnology Services Provides Internet related software | Technology Services |
BonitaSoft SA
 BonitaSoft SA Packaged SoftwareTechnology Services Develops open source BPM software platform | Technology Services |
eXo Platform SAS
 eXo Platform SAS Packaged SoftwareTechnology Services Provides information technology products and services | Technology Services |
Flash Therapeutics SAS
Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Provides biotechnology products for medical research | Commercial Services |
iDbyMe SA
iDbyMe SA Catalog/Specialty DistributionRetail Trade Sells clothes online | Retail Trade |
Miliboo SA
 Miliboo SA Home FurnishingsConsumer Durables Engages in manufacturing and marketing furniture and decorative objects | Consumer Durables |
Amoéba SA
 Amoéba SA Household/Personal CareConsumer Non-Durables Manufactures chemical biocides | Consumer Non-Durables |
Isocell SA
Isocell SA Food RetailRetail Trade Perates as a holding company with interests in the manufacture and sale of food supplements | Retail Trade |
College des Ingenieurs
 College des Ingenieurs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Firalis SA
Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Health Technology |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Health Services |
Pylote SA
Pylote SA BiotechnologyHealth Technology Conceives and develops mineral microspheres to sell solutions | Health Technology |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries Develops yeast for the production of chemical compounds | Process Industries |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Operates as anti-infective drug discovery platform | Health Technology |
